Advanced search
Publication Cover
International Journal of Neuroscience Volume 128, 2018 - Issue 12
Submit an article Journal homepage
150
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Optical coherence tomography (OCT) study in Argentinean Huntington’s disease patients

Emilia GattoDepartment of Neurology, Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina; ;Department of Movement Disorders, Fundación INEBA, Buenos Aires, Argentina; Correspondence[email protected]
View further author information
,
Virginia ParisiDepartment of Neurology, Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina; View further author information
,
Gabriel PersiDepartment of Neurology, Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina; View further author information
,
Estela Fernandez ReyDepartment of Neuro-opthamology, Hospital Oftalmológico Santa Lucía, Buenos Aires, Argentina; View further author information
,
Martin CesariniDepartment of Neuro-opthamology, Hospital Oftalmológico Santa Lucía, Buenos Aires, Argentina; View further author information
,
José Luis EtcheverryDepartment of Neuro-opthamology, Hospital Oftalmológico Santa Lucía, Buenos Aires, Argentina; View further author information
,
Pablo RiveraDepartment of Neuro-opthamology, Hospital Oftalmológico Santa Lucía, Buenos Aires, Argentina; View further author information
&
Ferdinando SquitieriHuntington and Rare Diseases Unit at IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyView further author information
 show all
Pages 1157-1162 | Received 24 Sep 2017, Accepted 09 May 2018, Published online: 21 Aug 2018

References

  • Weir DW, Sturrock A, Leavitt BR. Development of biomarkers for Huntington’s disease. Lancet Neurol. 2011;6:573–590.
  • Satue M, Obis J, Rodrigo MJ, et al. Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases. J Ophthalmol. 2016;2016:8503859.
  • Galetta K, Calabresi P, Frohman E, et al. Optical coherence tomography (OCT): imaging the visual pathway as a model of neurodegeneration. Neurotherapeutics. 2011;8:117–122.
  • Inzelberg R, Ramirez J, Nisipeanu P, et al. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004;44:2793–2797.
  • den Haan J, Verbraak FD, Visser PJ, et al. Retinal thickness in Alzheimer’s disease: a systematic review and meta-analysis. Alzheimers Dementia (Amst). 2017;6:162–170.
  • Albrecht P, Müller AK, Südmeyer M, et al. Optical coherence tomography in parkinsonian syndromes. PLoS One. 2012;7:e34891.
  • Simao LM. The contribution of optical coherence tomography in neurodegenerative diseases. Curr Opin Ophthalmol. 2013;24:521–527.
  • Jackson GR, Salecker I, Dong X, et al. Polyglutamine-expanded human Huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron. 1998;3:633–642.
  • Helmlinger D, Yvert G, Picaud S, et al. Progressive retinal degeneration and dysfunction in R6 Huntington’s disease mice. Hum Mol Genet. 2002;11:3351–3359.
  • Ragauskas S, Leinonen H, Puranen J, et al. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington’s disease. PLoS One. 2014;12:3351–3359.
  • Andrade C, Beato J, Monteiro A, et al. Spectral-domain optical coherence tomography as a potential biomarker in Huntington’s disease. Mov Disord. 2016;31:377–383.
  • Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979;29:1–3.
  • Kersten HM, Danesh-Meyer HV, Kilfoyle DH, et al. Optical coherence tomography findings in Huntington’s disease: a potential biomarker of disease progression. J Neurol. 2015;11:2457–2465.
  • Mailankody P, Battu R, Khanna A, et al. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson’s disease. Parkinsonism Relat Disord. 2015;10:1164–1169.
  • Kaur M, Saxena R, Singh D, et al. Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol. 2015;3:254–258.
  • Tariq YM, Li H, Burlutsky G, et al. Retinal nerve fiber layer and optic disc measurements by spectral domain OCT: normative values and associations in young adults. Eye (Lond). 2012;12:1563–1570.
  • Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by stratus OCT. Ophthalmology. 2007;6:1046–1052.
  • Sari ES, Koc R, Yazici A, et al.. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. J Neuroophthalmol. 2015;35(2):117–121.
  • Kwon JY, Yang JH, Han JS, et al. Analysis of the retinal nerve fiber layer thickness in Alzheimer disease and mild cognitive impairment. Korean J Ophthalmol. 2017;31(6):548–556.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.